FTC/TAF

With solid results in hand, Gilead inks manufacturing deal for HIV med
Biopharma Dive
Thu, 10/5/17 - 10:19 am
Gilead Sciences
HIV
drug manufacturing
FTC/TAF
Gilead circles February 12 on its calendar as D-day for its HIV franchise
Endpoints
Fri, 08/11/17 - 10:56 am
Gilead Sciences
HIV
FTC/TAF
FDA
Gilead details its case for a new HIV flagship triple, with megablockbuster potential
Endpoints
Mon, 07/24/17 - 10:43 am
Gilead Sciences
HIV
bictegravir
FTC/TAF
Gilead racing to FDA with a new HIV cocktail boasting megablockbuster potential
Endpoints
Thu, 06/1/17 - 09:14 am
Gilead Sciences
FDA
HIV
FTC/TAF